New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 21, 2014
19:02 EDTNFLX, RMBS, VRX, AGNOn The Fly: After Hours Movers
NOTABLE: Allergan (AGN), up 20%, and Valeant Pharmaceuticals (VRX), up 9.1%, both advanced after The Wall Street Journal reported that activist investor Bill Ackman is teaming up with Valeant to make a bid for Allergan. Following the report, Ackman's Pershing Square filed a 13D with the SEC disclosing a 9.7% stake in Allergan and outlining an agreement with Valeant. The agreement, among other things, said that Valeant plans to make a bid for Allergan comprised of $15B of cash and a to-be-determined amount of Valeant stock. The filing also showed that Ackman began building a position in Allergan in late February, and at that time entered an agreement with Valeant forming a new, jointly-owned entity through which to acquire a position in Allergan. CNBC's David Faber reported that Valeant is expected to officially make a hostile bid for Allergan by tomorrow. UP AFTER EARNINGS: Netflix (NFLX) gained 6.3% after reporting profits that beat expectations on revenues that were in-line with expectations. The streaming internet video service also reported that U.S. subscribers grew by 2.25M in the first quarter, with its international subscriber base expanding by 1.75M for the period. DOWN AFTER EARNINGS: Rambus (RMBS) fell 7.5% after providing a second quarter revenue outlook that fell short of expectations, with the company adding that its revenue outlook, "includes expectations that the company will sign new customers for patent as well as solutions licensing." Rambus' first quarter results, however, came in better than expected, and the company also reaffirmed its fiscal 2014 revenue outlook.
News For AGN;VRX;NFLX;RMBS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 >>
August 25, 2015
16:06 EDTNFLXOptions Update; August 25, 2015
Subscribe for More Information
12:20 EDTNFLXOn The Fly: Top stock stories at midday
Subscribe for More Information
11:28 EDTNFLXNetflix volatility elevated on wide price movement
Netflix August weekly call option implied volatility is at 101, September is at 71, compared to its 52-week range of 23 to 88, suggesting larger near term price movement.
09:46 EDTNFLXNetflix fades from initial gap high, levels to watch
Subscribe for More Information
09:35 EDTNFLXActive equity options trading on open
Subscribe for More Information
08:14 EDTAGNAllergan multiple is low, says Leerink
Leerink predicts that Allergan's 2016 EPS will come in at $17-$18. The firm thinks the company has "durable revenue streams," and a "deep pipeline with several potential blockbuster candidates." Leerink adds that the company "has significant capacity for M&A." It keeps a $388 price target and Outperform rating on the shares.
08:05 EDTVRXValeant names D. Robert Hale to board of directors
Valeant Pharmaceuticals International announced the addition of D. Robert Hale, Partner of ValueAct Capital, to its board of directors and the resignation of Jeffrey W. Ubben, CEO and CIO of ValueAct Capital, effective as of August 19, 2015. ValueAct Capital, an investment firm based in San Francisco with over $20B under management, owns approximately 4% of the outstanding stock of Valeant, and has been a shareholder in Valeant since 2006. As a Partner and member of the investment team of ValueAct Capital, Hale has worked closely with the board and management team of Valeant since January 2011. Hale will be the fourth Partner of ValueAct Capital to serve on the Valeant Board, following Mason Morfit, Brandon Boze, and Jeff Ubben.
06:18 EDTNFLXNetflix to add properties focused on teens and 'tweens,' NYT reports
Netflix (NFLX) will add a number of exclusive films and television programs focused on teenagers and "tweens," the New York Times reports. Some of the properties recently licensed by the streaming service include "Smosh: The Movie" from the creators of the YouTube (GOOG) channel of the same name and "Bad Night" featuring YouTube stars Jenn McAllister and Lauren Luthringshausen, the report says.
August 24, 2015
18:02 EDTNFLXS&P 500 enters correction territory amid global growth concerns
Subscribe for More Information
16:00 EDTNFLXOptions Update; August 24, 2015
Subscribe for More Information
14:15 EDTNFLXNetflix tests $100 area
Shares were last at $100.67. At that price next support is at $98.13 and then at $94.93. Resistance is at $102.31.
13:46 EDTNFLXNetflix turns negative on the session, levels to watch
Subscribe for More Information
09:36 EDTNFLXActive equity options trading on open
Active equity options trading on open: AAPL FB BAC NFLX
09:21 EDTNFLXNetflix plunges over 12% in pre-market
Subscribe for More Information
08:51 EDTNFLXNetflix confirms partnership with SoftBank ahead of Japan launch
SoftBank Corp (SFTBF) and Netflix (NFLX) confirmed that SoftBank, among Japanese telecommunications companies, will exclusively offer a fully integrated Netflix experience, including billing, when Netflix Japan launches on September 2. Under the agreement, SoftBank customers will be able to sign up for Netflix at SoftBank Shops, major electronics retailers, via the SoftBank website and via SoftBank call centers without filling out payment information, with Netflix's monthly fee added to their bill. In addition, SoftBank will begin pre-installing the Netflix app on its smartphones for sale after October 2015.
08:37 EDTAGNAllergan recalls certain lots of REFRESH, FML, Blephamide treatments
Allergan announced that it is conducting a voluntary recall down to consumer level of specific lots of its REFRESH Lacri-Lube 3.5g and 7g for dry eye, REFRESH P.M. 3.5g for dry eye, FML 0.1%, and Blephamide 10%/0.2% sterile topical ophthalmic ointment combining an antibacterial and a corticosteroid, 3.5g. Allergan chose to initiate this recall based on a small number of customer complaints which reported a small black particle at the time of use. Allergan has informed the U.S. Food and Drug Administration of this voluntary recall. Allergan is contacting retailers and wholesalers who have been shipped affected product lots to initiate the recall and is informing them of the steps needed to return affected product.
08:28 EDTNFLXNetflix volatility elevated
Subscribe for More Information
08:05 EDTNFLXFacebook Netflix TubeMogul best Internet pullback opportunities,says Oppenheimer
Oppenheimer sees Facebook (FB) Netflix (NFLX) and TubeMogul (TUBE) as providing the best buying opportunities among Internet stocks. The firm notes that the growth of Facebook's usage minutes fell to 17% year-over-year in July from a 20% increase in June and a 21% increase in May. However, the firm notes that the company maintained its 21% share of time on mobile devices. The firm thinks that the company's earnings could be boosted in the near-term by the launch of performance-based ads on Instagram. Oppenheimer notes that Netflix has risks from U.S. dollar appreciation and investors' skepticism towards stocks whose value is based on expected long-term growth. TubeMogul could be hurt by perceived risks to global macro growth, according to the firm.Despite these risks, the firm thinks that Facebook's stock could rise 27% above its $110 price target. It believes that Netflix's stock could jump 15% above its $125 price target and it thinks that TubeMogul could surpass its $19 price target by 83%.
06:30 EDTNFLXDiscovery exec: Group in 'hand to hand combat' with Netflix, Guardian says
Subscribe for More Information
06:07 EDTNFLXNetflix partners with SoftBank ahead of Japan launch, Japan Times reports
Subscribe for More Information
1 | 2 | 3 | 4 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use